The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease

The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease

Show other versions (1)

Aim.The aim of the study is the analysis of risk factors, influencing on the progression of chronic obstructive pulmonary disease. Materials and methods. 259 patients with chronic obstructive pulmonary disease (COPD) I and III stages, mean age 54,3±11,7 and the duration of the disease 10,1±5,7. Pati...

Full description

Bibliographic Details
Main Authors:	V A Nikitin, I A Starodubtseva, L V Vasilieva, A V Popov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2018-01-01
Series:	Терапевтический архив
Subjects:	chronic obstructive pulmonary disease risk factors progression markers of systemic inflammation
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32696/pdf

Similar Items

The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease
by: V.A. NIKITIN, et al.
Published: (2018-01-01)

PHYSICAL TRAINING IS A UNIVERSAL METHOD OF PULMONARY REHABILITATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N N Mescheryakova, et al.
Published: (2012-03-01)

Issues related to the combination of chronic obstructive pulmonary disease and osteoporosis (review)
by: V. V. Gaynitdinova, et al.
Published: (2019-12-01)

Chronic obstructive pulmonary disease concurrent with metabolic syndrome: Pathophysiological and clinical features
by: A V Budnevsky, et al.
Published: (2017-01-01)

Influence of inflammatory cytokines on the course of chronic obstructive pulmonary disease
by: L.B. Vynnychenko, et al.
Published: (2021-02-01)

Activity of systemic inflammatory reaction in patients with chronic obstructive pulmonary disease in regard to small intestinal absorption function
by: E I Beloborodova, et al.
Published: (2009-03-01)

Clinical releveance of hemorrhagic component of endobronchial inflammation in severe chronic obstructive pulmonary disease exacerbation
by: M L Shteiner, et al.
Published: (2019-03-01)

Trends in Hospital Admissions for Chronic Obstructive Pulmonary Disease in Men and Women in Spain, 1998 to 2018
by: Domingo Orozco-Beltrán, et al.
Published: (2021-04-01)

The functions of CD4 T-helper lymphocytes in chronic obstructive pulmonary disease
by: Qin Keru, et al.
Published: (2021-12-01)

Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity
by: E. S. Ovsyannikov, et al.
Published: (2020-03-01)

Anemias in chronic obstructive pulmonary disease
by: A V Budnevsky, et al.
Published: (2016-03-01)

Association of blood cadmium concentration with chronic obstructive pulmonary disease progression: a prospective cohort study
by: Jing Sun, et al.
Published: (2024-02-01)

A temporal visualization of chronic obstructive pulmonary disease progression using deep learning and unstructured clinical notes
by: Chunlei Tang, et al.
Published: (2019-12-01)

Oxidative and nitrosative stress — the leading mechanisms of chronic pancreatitis and chronic obstructive pulmonary disease interaction and inducers of their progression
by: O.S. Khukhlina, et al.
Published: (2023-12-01)

Clinical Features and the NT-proBNP Marker in Patients with Chronic Heart Failure in the Setting of Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
by: Т. A. Dzyurich, et al.
Published: (2019-09-01)

Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease
by: Priti Lokesh Meshram, et al.
Published: (2018-01-01)

CYTOTOXIC LYMPHOCYTES: THE ROLE IN INFLAMMATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION AND REMISSION
by: N. A. Raspopina, et al.
Published: (2016-02-01)

METHOD FOR THE PREDICTION OF THE DEVELOPMENT OF CHRONIC PULMONARY HEART IN COAL WORKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. Yu. Korotenko, et al.
Published: (2013-05-01)

Comparing frequencies of asthma-chronic obstructive pulmonary disease overlap in patients with stable chronic obstructive pulmonary disease
by: Nezar R. Mohamed, et al.
Published: (2019-07-01)

Biomarkers in chronic obstructive pulmonary disease patients for prediction of lung cancer development
by: Murali M S Balla, et al.
Published: (2018-01-01)

The role of cytokines in the development of systemic inflammation in chronic obstructive pulmonary disease and obesity
by: A. Yu. Blagov, et al.
Published: (2023-04-01)

Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease
by: Tamer A. Helmy, et al.
Published: (2016-02-01)

Hypogonadism in chronic obstructive pulmonary disease (COPD): Risk factors
by: Novković Ljiljana, et al.
Published: (2019-01-01)

IMMUNE AND METABOLIC PHENOTYPES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEN
by: E. P. Kalinina, et al.
Published: (2014-08-01)

Review of the association between periodontitis and chronic obstructive pulmonary disease in smokers
by: Agathi Spiropoulou, et al.
Published: (2019-03-01)

IL-36 is Closely Related to Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease
by: Huang S, et al.
Published: (2022-06-01)

Functional and radiological characteristics of asthma combined chronic obstructive pulmonary disease overlap
by: Hamada K. Fayed, et al.
Published: (2020-01-01)

Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients
by: Christina Marisa Bergsøe, et al.
Published: (2021-05-01)

EFFECTIVENESS OF THE PULMONARY REHABILITATION PROGRAMME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND OBESITY
by: Evgeny S. Ovsyannikov, et al.
Published: (2019-07-01)

Arterial hypertension and chronic obstructive pulmonary disease: pathogenetic parallels and clinicofunctional features
by: V. S Zadionchenko, et al.
Published: (2010-03-01)

Phenotypes of patients with chronic obstructive pulmonary disease
by: A V Aver'yanov, et al.
Published: (2009-03-01)

The influence of adequate drug therapy on the clinical symptoms and level of serum amyloid A in patients with chronic obstructive pulmonary disease.
by: T. A. Pertseva, et al.
Published: (2018-05-01)

Role of neutrophil to lymphocyte ratio in prediction of acute exacerbation of chronic obstructive pulmonary disease
by: Aida M. Yousef, et al.
Published: (2017-01-01)

Association between blood pressure, inflammation and spirometry parameters in chronic obstructive pulmonary disease
by: Sulhattin Arslan, et al.
Published: (2019-01-01)

CLINICAL AND IMMUNOLOGICAL CORRELATIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BRONCHIAL ASTHMA
by: E. G. Shuganov, et al.
Published: (2016-02-01)

DEVELOPMENT MECHANISMS AND CLINICAL SIGNIFICANCE OF ANEMIA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. V. Kovchun, et al.
Published: (2020-10-01)

ROLE OF IL-4, IL-6, IL-8, IL-10 CYTOKINES IN THE IMMUNOPATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. Yu. Trushina, et al.
Published: (2019-01-01)

Peculiarities of coagulation hemostasis disorders in patients with chronic obstructive pulmonary disease.
by: V. H. Yakovlieva
Published: (2015-09-01)

Extra pulmonary boosting in chronic obstructive pulmonary disease: leverage of piracetam as an adjunctive therapy on respiratory and neuropsychiatric functions in patients with chronic obstructive pulmonary disease
by: Ahmed M Abumossalam, et al.
Published: (2021-01-01)

Bone mineral density in patients with chronic obstructive pulmonary disease
by: E V Kochetova, et al.
Published: (2013-03-01)